US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 0.9283
  • -0.0127-1.35%
Close Dec 20 16:00 ET
  • 0.9865
  • +0.0582+6.27%
Post 17:42 ET
171.23MMarket Cap-1.11P/E (TTM)

Nektar Therapeutics Key Stats

Nektar Therapeutics Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
18.28M
24.12M
+5.84M
Beat Est.
-24.29%
-0.08%
+31.97%
EPS
-0.21
-0.18
+0.03
Beat Est.
+12.13%
+25.00%
+14.61%
Strong Buy

Dec 12, 2024

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 23.720M--
--2024/Q4-- / 38.043M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 23.720M--
--2024/Q4-- / 38.043M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Dec 12, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Price
% Chg

No Data